A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2004
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483247A2 Aryl substituted pyrimidines and the use thereof
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483232A1 Salts of nateglinide
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004	EP1482950A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482936A1 Ophthalmic composition comprising ascomycin
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482922A1 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1305286B1 Cyclopentanoindoles, compositions containing such compounds and methods of treatment
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1171107B1 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa
12/08/2004	EP1121354B1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h 3 agonists or antagonists
12/08/2004	EP0863729B1 Implantable controlled release device to deliver drugs directly to an internal portion of the body
12/08/2004	EP0812190B1 R-enantiomer of n-propargyl-1-aminoindan for the treatment of various diseases and mesylate, esylate and sulfate thereof
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553816A Polysaccharide-containing compositions and use thereof
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552443A Lysozyme injection preparation
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178661C Use of brinzolamide to prevent visual field loss
12/08/2004	CN1178656C Pharmaceutical composition
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828317 Bactericides; gramnegative, grampositive bacteria
12/02/2004	WO2004103376A2 Skin treatments
12/02/2004	WO2004103373A1 Ophthalmic solution containing quinolone antimicrobial compound
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242654 Diaryl ether derivative, addition salt thereof, and immunosuppressant
12/02/2004	US20040242647 Use of organic compounds
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242545 Remedy for glaucoma comprising as the active ingredient compound having p13 kinase inhibitory effect
12/02/2004	US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin
12/02/2004	US20040242457 Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241206 Use of nanoparticles as carriers for biocides in ophthalmic compositions
12/02/2004	US20040241184 Fermentation product of cyptoporous volvatus and its preparation method and use
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481668A1 Use of anti-glaucoma drugs to treat visual field defects associated with the use of a GABAergic agent
12/01/2004	EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
12/01/2004	EP1480983A1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
12/01/2004	EP1480981A1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
12/01/2004	EP1480970A1 Quinoline derivatives
12/01/2004	EP1480964A1 Inhibiteurs de l'angiogenese
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480678A2 Treatment of ophthalmic disorders using urea and urea derivatives
12/01/2004	EP1480677A2 Composition for stabilizing hyaluronic acid
12/01/2004	EP1480656A1 Hyaluronic acid mediated adenoviral transduction
12/01/2004	EP1480627A1 Methods of reducing angiogenesis
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1173403B1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
12/01/2004	EP1104407B1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551914A FAD4, FAD5, FAD5-2 and FAD6, novel fatty acid desaturase family members and uses thereof
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1551775A Remedies for retina and choroid diseases containing steroids as the active ingredient
12/01/2004	CN1551773A Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551766A Lymphocytic activation inhibitor and remedial agent for autoimmune disease
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177821C Matrix metalloprotease inhibitors

1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 531